Background: New treatments are available for treatment of venous thromboembolism.
Purpose: To review the evidence on the efficacy of interventions for treatment of deep …

Venous thromboembolism is a common condition affecting 7.1 persons per 10 000 person-
years among community residents. Incidence rates for venous thromboembolism are higher …

Importance Venous thromboembolism (VTE), comprising deep vein thrombosis (DVT) and
pulmonary embolism (PE), is a common, potentially lethal condition with acute morbidity …

Venous thromboembolism, including deep vein thrombosis and pulmonary embolism,
represents a significant source of morbidity and mortality in the United States and worldwide …

Pulmonary embolism and deep venous thrombosis are the two most important
manifestations of venous thrombo-embolism (VTE), which is the third most common life …

This chapter about treatment for venous thromboembolic disease is part of the American
College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) …

This review on the treatment of patients with venous thromboembolic disease consists of
three sections. The first section describes the epidemiology, natural history and reasons for …

Objectives To compare the efficacy and safety of unfractionated heparin (UFH) and low-
molecular-weight heparins (LMWHs) and to examine current controversies in the treatment …

This chapter about antithrombotic therapy for venous thromboembolic disease is part of the
seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy: Evidence Based …

Venous thromboembolism, which includes deep-vein thrombosis (usually involving leg
veins) and pulmonary embolism, is a common cause of death. Treatment of affected patients …